Endo International | ENDP - Capitale Ordinario



Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 1.75B 2025-06
Amarin USD 20.81M 13K 2025-12
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Coherus Biosciences USD 121.16M 4.92M 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Heron Therapeutics USD 188.31M 4.99M 2025-12
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.91B 10.64M 2025-12
Pacira USD 41.12M 1.85M 2025-12
Perrigo USD 137.6M 0 2025-12
Pfizer USD 5.69B 1000K 2025-09
Phibro Animal Health USD 40.48M 0 2025-12
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
Takeda JPY 1.58B 2K 2025-12
Teva Pharmaceutical Industries USD 1.15B 0 2025-12
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12
Zoetis USD 424.93M 16.54M 2025-12